ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO272

Effects and Dynamics of D-alanine under Diabetic Conditions

Session Information

Category: Diabetic Kidney Disease

  • 701 Diabetic Kidney Disease: Basic

Authors

  • Kimura, Tomonori, Osaka Daigaku, Suita, Osaka, Japan
  • Sakai, Shinsuke, Osaka Daigaku, Suita, Osaka, Japan
  • Mita, Masashi, Kagami Inc., Ibaraki, Japan
  • Mizui, Masayuki, Osaka Daigaku, Suita, Osaka, Japan
  • Isaka, Yoshitaka, Osaka Daigaku, Suita, Osaka, Japan
Background

D-Alanine, a rare enantiomer of alanine, protects from viral infections and mediates renal gluconeogenesis through the transcriptional network of circadian clock. These features of D-alanine are associated with the diabetic conditions; the aberrant circadian rhythm is a feature of diabetes, and diabetes is a worsening factor for Covid-19. This study investigated the effects and dynamics of D-alanine in the diabetic conditions.

Methods

The blood and urinary levels of D-alanine in diabetic model mice and in patients with diabetic kidney disease were measured using two-dimensional high performance liquid chromatography system. Gluconeogenetic activity of D-alanine was analysed using glucose production assay in ex vivo-cultured kidney cells. Glucose tolerance test was performed in mice treated with D-alanine.

Results

The circadian rhythm of D-alanine, which is clearly present in mice, was lost in mice model of diabetes. The urinary excretion profile of D-alanine was abnormal in patients with diabetic kidney disease. Like normal kidney, D-alanine induced gluconeogenesis in kidney from diabetic model mice. While treatment of D-alanine induced the transient increase of blood glucose level, repetitive treatment of D-alanine did not worsen the glucose tolerance.

Conclusion

D-Alanine also acts on the kidney from diabetic mice, whereas treatment of d-alanine does not worsen the diabetic conditions. D-Alanine may provide a therapeutic option for diabetes through the correction of circadian rhythm and treatment of viral infections.